# ONO-7913 Phase I Study (ONO-7913)

> **NCT04403308** · PHASE1 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** ONO-7913

## Key facts

- **NCT ID:** NCT04403308
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2022-01-13
- **Final completion:** 2022-01-13
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403308, "ONO-7913 Phase I Study (ONO-7913)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04403308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*